XML 105 R88.htm IDEA: XBRL DOCUMENT v3.20.4
STOCK-BASED COMPENSATION - SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 47.11 $ 35.01 $ 40.74  
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 305,269 195,305 138,896 148,508
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 49.56 $ 54.64 $ 62.80  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Stock-settled appreciation rights granted 158,756 126,874 44,144  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 13.86 $ 16.36 $ 18.38  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 391,339 113,099 192,700  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 46,245 115,103 203,320  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 65.93 $ 65.27 $ 68.69  
Weighted Average Remaining Contractual Term, Outstanding 5 years 8 months 12 days      
Weighted Average Remaining Contractual Term, Exercisable 4 years 9 months 18 days      
Aggregate Intrinsic Value, Outstanding $ 39,834      
Aggregate Intrinsic Value, Exercisable $ 26,622      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,630,891 1,723,370 1,453,932  
Stock-settled appreciation rights granted 262,091 213,618 509,046  
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $ 62.72 $ 59.00 $ 57.93  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 60.48 $ 59.72 $ 59.26 $ 57.75
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,161,556 2,337,049 2,351,633 2,238,607
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 48.32 $ 54.63 $ 62.68  
Share-based Payment Arrangement, Tranche Two [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 132,838      
Share-based Payment Arrangement, Tranche Two [Member] | Net Income Growth Rate [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 19,797